Blueprint Medicines


Blueprint Medicines Corp Bullish Stance Reiterated At Wedbush Following FDA Clearance Of Two INDs

Blueprint Medicines Corp (NASDAQ:BPMC) has been reiterated as an Outperform at Wedbush by research analyst David Nierengarten in a recent report released yesterday. The …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts